Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin and Tadalafil for Lower Ureteric Stones
NCT05789732Completed
- Sponsor
- Benha University
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of silodosin and tadalafil in ureteric stone, sponsored by Benha University. Started Mar 2022; status: completed.
02
Drugs
silodosintadalafil
03
Conditions
ureteric stone
Beyond the preview
Go deeper on NCT05789732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05789732.